Journal
ANNALS OF ONCOLOGY
Volume 16, Issue 4, Pages 625-633Publisher
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdi119
Keywords
autologous stem cell transplantation; first relapse; Hodgkin's lymphoma
Categories
Ask authors/readers for more resources
Purpose: To analyse outcome and prognostic factors for overall survival (OS) and time to treatment failure (TTF) in 357 patients with Hodgkin's lymphoma (HL) undergoing an autologous stem cell transplantation (ASCT) after a first relapse and reported to the The Grupo EspaNol de Linfomas/ Trasplante AutOlogo de MEdula Osea (GEL/TAMO) Cooperative Group. Methods: Two hundred and twenty mates and 137 females with a median age of 29 years were autografted in second remission (n = 18 1), first sensitive relapse (n = 148) and first resistant relapse (n = 28). Results: Five-year actuarial TTF and OS were of 49% 3% and 57% 3%. Advanced stage at diagnosis, complementary radiotherapy before ASCT, a short first complete response (CR) and detectable disease at ASCT adversely influenced TTF. Year of transplant <= 1995, bulky disease at diagnosis, a short first CR, detectable disease at ASCT and >= 1 extranodal areas involved at ASCT were adverse factors for OS. Conclusions: ASCT constitutes a therapeutic option for HL patients after a first relapse. Promising results are observed in patients with low tumour burden at diagnosis, autografted after a long CR and without detectable disease at ASCT. Innovative approaches should be pursued for patients with risk factors at relapse.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available